CTOs on the Move

RSi Communications Group

www.rsicommunications.com

 
RSi Communications Group is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Wabash County Hospital

Wabash County Hospital is a county-owned, critical access hospital. With 25 inpatient beds, we offer critical care services, emergency services, cancer treatment and much more.

Cover Oregon

Cover Oregon was created for Oregonians by Oregonians. We're one of the first states to build our own health insurance marketplace. We're setting the standard for making health coverage more accessible and easier to understand. We're improving the health of all Oregonians by providing health coverage options, increasing access to information and fostering quality and value in the health care system.

Blue Cross and Blue Shield of Mississippi (BCBSMS)

Blue Cross and Blue Shield of Mississippi (BCBSMS) is a Jackson, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atlanta Prosthetics and Orthotics

Atlanta Prosthetics and Orthotics is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

StemCells

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.